473 related articles for article (PubMed ID: 19376202)
21. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats.
Pathan AR; Viswanad B; Sonkusare SK; Ramarao P
Life Sci; 2006 Nov; 79(23):2209-16. PubMed ID: 16904700
[TBL] [Abstract][Full Text] [Related]
22. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.
Ishrat T; Khan MB; Hoda MN; Yousuf S; Ahmad M; Ansari MA; Ahmad AS; Islam F
Behav Brain Res; 2006 Jul; 171(1):9-16. PubMed ID: 16621054
[TBL] [Abstract][Full Text] [Related]
23. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
[TBL] [Abstract][Full Text] [Related]
24. Lycopene attenuates diabetes-associated cognitive decline in rats.
Kuhad A; Sethi R; Chopra K
Life Sci; 2008 Jul; 83(3-4):128-34. PubMed ID: 18585396
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
[TBL] [Abstract][Full Text] [Related]
26. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats.
Rizk NN; Rafols J; Dunbar JC
Brain Res; 2005 Aug; 1053(1-2):1-9. PubMed ID: 16038884
[TBL] [Abstract][Full Text] [Related]
27. Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats.
Shingo AS; Kanabayashi T; Kito S; Murase T
Behav Brain Res; 2013 Mar; 241():105-11. PubMed ID: 23238038
[TBL] [Abstract][Full Text] [Related]
28. Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats.
Borlongan CV; Sumaya IC; Moss DE
Brain Res; 2005 Mar; 1038(1):50-8. PubMed ID: 15748872
[TBL] [Abstract][Full Text] [Related]
29. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
[TBL] [Abstract][Full Text] [Related]
30. Suppressive effects of melatonin on amyloid-beta-induced glial activation in rat hippocampus.
Shen Y; Zhang G; Liu L; Xu S
Arch Med Res; 2007 Apr; 38(3):284-90. PubMed ID: 17350477
[TBL] [Abstract][Full Text] [Related]
31. Nongenetic model of type 2 diabetes: a comparative study.
Islam MS; Choi H
Pharmacology; 2007; 79(4):243-9. PubMed ID: 17457033
[TBL] [Abstract][Full Text] [Related]
32. PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.
Jiang LY; Tang SS; Wang XY; Liu LP; Long Y; Hu M; Liao MX; Ding QL; Hu W; Li JC; Hong H
CNS Neurosci Ther; 2012 Aug; 18(8):659-66. PubMed ID: 22620268
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).
Ishrat T; Hoda MN; Khan MB; Yousuf S; Ahmad M; Khan MM; Ahmad A; Islam F
Eur Neuropsychopharmacol; 2009 Sep; 19(9):636-47. PubMed ID: 19329286
[TBL] [Abstract][Full Text] [Related]
34. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
Sharma B; Singh N; Singh M
J Psychopharmacol; 2008 Mar; 22(2):162-71. PubMed ID: 18208924
[TBL] [Abstract][Full Text] [Related]
35. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.
Tiwari V; Kuhad A; Bishnoi M; Chopra K
Pharmacol Biochem Behav; 2009 Aug; 93(2):183-9. PubMed ID: 19464315
[TBL] [Abstract][Full Text] [Related]
36. CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function.
Lee YK; Kwak DH; Oh KW; Nam SY; Lee BJ; Yun YW; Kim YB; Han SB; Hong JT
Neurobiol Learn Mem; 2009 Oct; 92(3):356-63. PubMed ID: 19394434
[TBL] [Abstract][Full Text] [Related]
37. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits.
Kuhad A; Bishnoi M; Tiwari V; Chopra K
Pharmacol Biochem Behav; 2009 Apr; 92(2):251-9. PubMed ID: 19138703
[TBL] [Abstract][Full Text] [Related]
38. Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats.
Liu Y; Liu H; Yang J; Liu X; Lu S; Wen T; Xie L; Wang G
Neuroscience; 2008 May; 153(3):796-802. PubMed ID: 18424002
[TBL] [Abstract][Full Text] [Related]
39. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
40. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
Lin HC; Hsieh HM; Chen YH; Hu ML
Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
